Severe A(H1N1)-associated Pneumonia Sequential to Clamidophila pneumoniae Infection in Healthy Subject

• Published in: In vivo (Athens) Vol. 25; no. 5; p. 825
• Main Authors: Bianco, Andrea, Parrella, Roberto, Esposito, Vincenzo, Mazzarella, Gennaro, Sammarco, Michela Lucia, Brunese, Luca, Ripabelli, Giancarlo
• Format: Journal Article
• Language: English
• Published: Greece 01.09.2011
• Subjects: Anti-Bacterial Agents - therapeutic use; Antiviral Agents - therapeutic use; Azithromycin - therapeutic use; Cephalosporins - therapeutic use; Chlamydophila Infections - complications; Chlamydophila Infections - diagnosis; Chlamydophila Infections - drug therapy; Chlamydophila pneumoniae; Coinfection; Drug Therapy, Combination; Fluoroquinolones - therapeutic use; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human - complications; Influenza, Human - diagnosis; Influenza, Human - drug therapy; Male; Middle Aged; Ofloxacin - therapeutic use; Oseltamivir - therapeutic use; Pneumonia, Viral - complications; Pneumonia, Viral - diagnosis; Pneumonia, Viral - drug therapy

Pandemic influenza virus has been implicated in serious lower airways illness and death in subjects both with and without underlying medical conditions. Predictive factors for severe disease in healthy individuals have not been identified. Severe A(H1N1)-associated pneumonia occurring in a healthy s...